SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-266274
Filing Date
2018-09-04
Accepted
2018-09-04 16:39:00
Documents
4
Period of Report
2018-09-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d617808d8k.htm 8-K 21501
2 EX-5.1 d617808dex51.htm EX-5.1 8902
3 EX-10.1 d617808dex101.htm EX-10.1 175927
4 GRAPHIC g617808g03u23.jpg GRAPHIC 3301
  Complete submission text file 0001193125-18-266274.txt   212285
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 181052783
SIC: 2834 Pharmaceutical Preparations